⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16855025 | 1.00 | — | — | |
| SCHEMBL5318944 | 1.00 | — | — | |
| SCHEMBL1971264 | 1.00 | — | — | |
| SCHEMBL3436779 | 1.00 | — | — | |
| SCHEMBL3379916 | 0.86 | GLB1 (0.48) | — | |
| SCHEMBL14426713 | 0.86 | GAA (0.48) | — | |
| SCHEMBL15599042 | 0.86 | GLB1 (0.48) | — | |
| SCHEMBL14426706 | 0.86 | GAA (0.48) | — | |
| SCHEMBL14426708 | 0.86 | GAA (0.48) | — | |
| SCHEMBL9710932 | 0.86 | GLB1 (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5872249-A | QUATERNIZATION, SALT FORMATION, AMINATION, DEALKYLATION | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 1999-02-16 | — | — | US | claimed |
| US-5675003-A | ACTIVITY AGAINST STAPHYLOCOCCUS, ENTEROBACTER | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 1997-10-07 | — | — | US | claimed |
| US-5571909-A | ANTIBIOTICS | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 1996-11-05 | — | — | US | claimed |
| JP-8283274-A | — | — | None | — | — | JP | disclosed |
| US-20260001846-A1 | SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS | SERVIER LAB (FR) | 2026-01-01 | — | — | US | disclosed |
| CN-119816491-A | New spirocyclohexane derivatives, pharmaceutical compositions containing them and their use as anti-apoptotic inhibitors | 法国施维雅药厂 | 2025-04-11 | — | — | CN | disclosed |
| WO-2023018812-A1 | HETEROCYCLIC COMPOUNDS AND METHODS OF USE | AMGEN INC. (US) | 2023-02-16 | — | — | WO | disclosed |
| EP-3238738-B1 | NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS | ARBUTUS BIOPHARMA CORP (CA) | 2020-09-23 | — | — | EP | disclosed |
| US-20170283424-A1 | PYRAZOLOPYRIMIDINE JAK INHIBITOR COMPOUNDS AND METHODS | GENENTECH, INC. (US) | 2017-10-05 | — | — | US | disclosed |
| US-20170190729-A1 | POLYENE MACROLIDE DERIVATIVE | SHIONOGI & CO., LTD. (JP) | 2017-07-06 | — | — | US | disclosed |
| WO-2016198342-A1 | POSITIVE ALLOSTERIC MODULATORS OF MUSCARINIC M2 RECEPTOR | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2016-12-15 | — | — | WO | disclosed |
| WO-2007096740-A2 | NOVEL CEPHALOSPORINS | ORCHID RESEARCH LABORATORIES LIMITED (IN) | 2007-08-30 | — | — | WO | disclosed |
| EP-1643998-B1 | DUAL NK1/NK3 ANTAGONISTS FOR TREATING SCHIZOPHRENIA | HOFFMANN LA ROCHE (CH) | 2007-08-29 | — | — | EP | disclosed |
| WO-2005002577-A1 | DUAL NK1/NK3 ANTAGONISTS FOR TREATING SCHIZOPHRENIA | F. HOFFMANN-LA ROCHE AG (CH) | 2005-01-13 | — | — | WO | disclosed |
| US-5872249-A | QUATERNIZATION, SALT FORMATION, AMINATION, DEALKYLATION | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 1999-02-16 | — | — | US | disclosed |
| US-5872249-A | QUATERNIZATION, SALT FORMATION, AMINATION, DEALKYLATION | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 1999-02-16 | — | — | US | disclosed |
| US-5675003-A | ACTIVITY AGAINST STAPHYLOCOCCUS, ENTEROBACTER | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 1997-10-07 | — | — | US | disclosed |
| US-5675003-A | ACTIVITY AGAINST STAPHYLOCOCCUS, ENTEROBACTER | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 1997-10-07 | — | — | US | disclosed |
| US-5571909-A | ANTIBIOTICS | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 1996-11-05 | — | — | US | disclosed |
| JP-H08283274-A | AMMONIOCEPHALOSPORIN-BASED ANTIBIOTIC AND ITS PRODUCTION | KOREA ADVANCED INST OF SCI TECHNOL | 1996-10-29 | — | — | JP | disclosed |